SCHEMBL29567420

SCHEMBL29567420

Cc1cccc(C)c1-c1cc(Oc2ccccc2)nc(NS(=O)(=O)c2ccccc2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.57
▸ TSHR P16473 2/20 0.57
▸ PKM P14618 2/20 0.48
▸ GAA P10253 1/20 0.48
▸ KDM4E B2RXH2 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ LMNA P02545 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ MAPT P10636 2/20 0.46
▸ PGR P06401 3/20 0.44
▸ GPR39 O43194 1/20 0.44
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GPR119 Q8TDV5 1/20 0.43
▸ CYTH2 Q99418 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ FFAR1 O14842 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310003 1.00 SMN1; SMN2 (0.57) SMN1; SMN2TSHRPKMGAAKDM4E
SCHEMBL26807086 0.92 TSHR (0.49) SMN1; SMN2TSHRPKMGAAKDM4E
SCHEMBL24309985 0.92 TSHR (0.56) SMN1; SMN2TSHRPKMGAAKDM4E
SCHEMBL26811103 0.90 TSHR (0.60) SMN1; SMN2TSHRPKMGAAKDM4E
SCHEMBL26810957 0.88 TSHR (0.54) SMN1; SMN2TSHRPKMGAAKDM4E
SCHEMBL26807087 0.87 PKM (0.50) SMN1; SMN2TSHRPKMKDM4EALDH1A1
SCHEMBL24298133 0.86 SMN1; SMN2 (0.45) SMN1; SMN2TSHRPKMALDH1A1LMNA
SCHEMBL29457761 0.86 SMN1; SMN2 (0.45) SMN1; SMN2TSHRPKMALDH1A1LMNA
SCHEMBL24310345 0.86 TSHR (0.43) SMN1; SMN2TSHRPKMGAAKDM4E
SCHEMBL29566612 0.86 TSHR (0.43) SMN1; SMN2TSHRPKMGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback